Sophia K. Berry, Dr

AstraZeneca, England, United Kingdom

Dr Sophia Berry is a Senior Scientist in the cell-based High-Throughput Screening team at AstraZeneca. Sophia obtained her PhD in 2019 from the University of Cambridge, where she worked on developing novel antibody-based therapeutics for the treatment of antibiotic-resistant pathogens. Prior to joining AstraZeneca, Sophia carried out postdoctoral research as an Open Lab Fellow at GSK's Diseases of the Developing World Unit in Madrid, where she developed high-content imaging assays to screen small-molecule libraries for compounds that alter the shape of enteric pathogens.

Disclosure information not submitted.

Presentation(s):

• HiBiT cellular thermal shift assays: Learnings from two high-throughput screening campaigns

  Monday, February 5, 2024
  4:00 PM – 4:30 PM EST